E 432 Pill - peach round, 11mm
Pill with imprint E 432 is Peach, Round and has been identified as Lamotrigine (Orally Disintegrating) 100 mg. It is supplied by Par Pharmaceutical Companies, Inc.
Lamotrigine is used in the treatment of Bipolar Disorder; Lennox-Gastaut Syndrome; Epilepsy; Seizure Prevention; Seizures and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for E 432
Lamotrigine (Orally Disintegrating)
- Imprint
- E 432
- Strength
- 100 mg
- Color
- Peach
- Size
- 11.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Triazine anticonvulsants
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Par Pharmaceutical Companies, Inc.
- National Drug Code (NDC)
- 49884-0486
- Inactive Ingredients
-
silicon dioxide,
mannitol,
corn starch,
peppermint,
sucralose,
magnesium stearate,
sodium stearyl fumarate,
microcrystalline cellulose,
croscarmellose sodium,
ferric oxide red
Note: Inactive ingredients may vary.
Related images for "E 432"
More about lamotrigine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,762)
- Drug images
- Latest FDA alerts (6)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: triazine anticonvulsants
- Breastfeeding
- En español
Patient resources
- Lamotrigine drug information
- Lamotrigine Chewable Dispersible Tablets
- Lamotrigine Orally Disintegrating Tablets
- Lamotrigine Extended-Release Tablets
- Lamotrigine Tablets
Other brands
Lamictal, Lamictal XR, Subvenite, Lamictal ODT, Lamictal CD
Professional resources
- Lamotrigine monograph
- Lamotrigine (FDA)
- Lamotrigine Chewable Tablet (FDA)
- Lamotrigine Extended Release Tablet (FDA)
- Lamotrigine ODT (FDA)
- Lamotrigine Tablets (FDA)
Other brands
Lamictal, Lamictal XR, Subvenite
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
